{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:01:07Z","timestamp":1790042467359,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06156-2","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:14:42Z","timestamp":1782976482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a triglyceride-glucose index-based nomogram for predicting risk in STEMI patients undergoing primary PCI"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinyong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhuang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"6156_CR1","doi-asserted-by":"publisher","unstructured":"Sivakanesan R, Ralapanawa U. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169\u201377. https:\/\/doi.org\/10.2991\/jegh.k.201217.001.","DOI":"10.2991\/jegh.k.201217.001"},{"key":"6156_CR2","doi-asserted-by":"publisher","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"6156_CR3","doi-asserted-by":"publisher","unstructured":"Gandhi S, Garratt KN, Li S, Wang TY, Bhatt DL, Davis LL, et al. Ten-year trends in patient characteristics, treatments, and outcomes in myocardial infarction from national cardiovascular data registry chest pain\u2013MI registry. Circ Cardiovasc Qual Outcomes. 2022;15(1):e008112. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.121.008112.","DOI":"10.1161\/CIRCOUTCOMES.121.008112"},{"key":"6156_CR4","doi-asserted-by":"publisher","unstructured":"Watanabe N, Takagi K, Tanaka A, Yoshioka N, Morita Y, Yoshida R, et al. Ten-year mortality in patients with ST-elevation myocardial infarction. Am J Cardiol. 2021;149:9\u201315. https:\/\/doi.org\/10.1016\/j.amjcard.2021.03.008.","DOI":"10.1016\/j.amjcard.2021.03.008"},{"key":"6156_CR5","doi-asserted-by":"publisher","unstructured":"Zhao D, Liu J, Xie W, Qi Y. Cardiovascular risk assessment: a global perspective. Nat Rev Cardiol. 2015;12(5):301\u201311. https:\/\/doi.org\/10.1038\/nrcardio.2015.28.","DOI":"10.1038\/nrcardio.2015.28"},{"key":"6156_CR6","doi-asserted-by":"publisher","unstructured":"Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000;102(17):2031\u20137. https:\/\/doi.org\/10.1161\/01.cir.102.17.2031.","DOI":"10.1161\/01.cir.102.17.2031"},{"key":"6156_CR7","doi-asserted-by":"publisher","unstructured":"Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study. BMJ. 2006;333(7578):1091. https:\/\/doi.org\/10.1136\/bmj.38985.646481.55.","DOI":"10.1136\/bmj.38985.646481.55"},{"key":"6156_CR8","doi-asserted-by":"publisher","unstructured":"Wang CH, Wang HT, Wu KH, Cheng FJ, Cheng CI, Kung CT, et al. Comparison of different risk scores for prediction of in-hospital mortality in STEMI patients treated with PPCI. Emerg Med Int. 2022;2022:5389072. https:\/\/doi.org\/10.1155\/2022\/5389072.","DOI":"10.1155\/2022\/5389072"},{"key":"6156_CR9","doi-asserted-by":"publisher","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4.","DOI":"10.1186\/s12933-018-0762-4"},{"key":"6156_CR10","doi-asserted-by":"publisher","unstructured":"Zhao Q, Cheng Y-J, Xu Y-K, Zhao Z-W, Liu C, Sun T-N, et al. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):190. https:\/\/doi.org\/10.1186\/s12933-021-01383-7.","DOI":"10.1186\/s12933-021-01383-7"},{"key":"6156_CR11","doi-asserted-by":"publisher","unstructured":"Park G-M, Cho Y-R, Won K-B, Yang YJ, Park S, Ann SH, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19(1):7. https:\/\/doi.org\/10.1186\/s12944-020-1187-0.","DOI":"10.1186\/s12944-020-1187-0"},{"key":"6156_CR12","doi-asserted-by":"publisher","unstructured":"Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol. 2023;22(1):87. https:\/\/doi.org\/10.1186\/s12933-023-01820-9.","DOI":"10.1186\/s12933-023-01820-9"},{"key":"6156_CR13","doi-asserted-by":"publisher","unstructured":"Cid Alvarez AB, Gomez-Pe\u00f1a F, Redondo-Dieguez A, Avila A, L\u00f3pez D, Sanmartin X, et al. Prognostic impact of the SYNTAX score II in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of a four-year all-comers registry. EuroIntervention. 2019;15(9):e796-803. https:\/\/doi.org\/10.4244\/EIJ-D-18-00561.","DOI":"10.4244\/EIJ-D-18-00561"},{"key":"6156_CR14","doi-asserted-by":"publisher","unstructured":"Tang J, Lai Y, Tu S, Chen F, Yao Y, Ye Z, et al. Quantitative flow ratio-guided residual functional SYNTAX score for risk assessment in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. EuroIntervention. 2021;17(4):e287\u201393. https:\/\/doi.org\/10.4244\/EIJ-D-19-00369.","DOI":"10.4244\/EIJ-D-19-00369"},{"key":"6156_CR15","doi-asserted-by":"publisher","unstructured":"Marquard JM, Beske RP, Kelb\u00e6k H, Holmvang L, Pedersen F, Clemmensen P, et al. 10-year outcome of complete or infarct artery-only revascularization in STEMI with multivessel disease: the DANAMI-3-PRIMULTI Study. J Am Coll Cardiol. 2025;86(2):119\u201329. https:\/\/doi.org\/10.1016\/j.jacc.2025.05.013.","DOI":"10.1016\/j.jacc.2025.05.013"},{"key":"6156_CR16","doi-asserted-by":"publisher","unstructured":"Mincu RI, J\u00e1nosi RA, Vinereanu D, Rassaf T, Totzeck M. Preprocedural C-reactive protein predicts outcomes after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a systematic meta-analysis. Sci Rep. 2017;7:41530. https:\/\/doi.org\/10.1038\/srep41530.","DOI":"10.1038\/srep41530"},{"key":"6156_CR17","doi-asserted-by":"publisher","unstructured":"Shon HS, Bae JW, Kim KO, Cha EJ, Kim KA. Biomarker for the prediction of major adverse cardiac events in patients with non-ST-segment elevation myocardial infarction. Osong Public Health Res Perspect. 2017;8(4):237\u201346. https:\/\/doi.org\/10.24171\/j.phrp.2017.8.4.02.","DOI":"10.24171\/j.phrp.2017.8.4.02"},{"key":"6156_CR18","doi-asserted-by":"publisher","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8. https:\/\/doi.org\/10.1186\/s12933-019-0982-2.","DOI":"10.1186\/s12933-019-0982-2"},{"key":"6156_CR19","doi-asserted-by":"publisher","unstructured":"Fang C, Chen Z, Zhang J, Jin X, Yang M. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Front Cardiovasc Med. 2022;9:1050785. https:\/\/doi.org\/10.3389\/fcvm.2022.1050785.","DOI":"10.3389\/fcvm.2022.1050785"},{"key":"6156_CR20","doi-asserted-by":"publisher","unstructured":"Alhamzawi R, Ali HTM. The Bayesian adaptive lasso regression. Math Biosci. 2018;303:75\u201382. https:\/\/doi.org\/10.1016\/j.mbs.2018.06.004.","DOI":"10.1016\/j.mbs.2018.06.004"},{"key":"6156_CR21","doi-asserted-by":"publisher","unstructured":"Gilhodes J, Dalenc F, Gal J, Zemmour C, Leconte E, Boher JM, et al. Comparison of variable selection methods for time-to-event data in high-dimensional settings. Comput Math Methods Med. 2020;2020:6795392. https:\/\/doi.org\/10.1155\/2020\/6795392.","DOI":"10.1155\/2020\/6795392"},{"key":"6156_CR22","doi-asserted-by":"publisher","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338. https:\/\/doi.org\/10.1097\/EDE.0b013e3181c30fb2.","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"6156_CR23","doi-asserted-by":"crossref","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","DOI":"10.18637\/jss.v033.i01"},{"key":"6156_CR24","doi-asserted-by":"publisher","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19970228)16:4%3C;385::aid-sim380%3E;3.0.co;2-3.","DOI":"10.1002\/(sici)1097-0258(19970228)16:4%3C;385::aid-sim380%3E;3.0.co;2-3"},{"key":"6156_CR25","doi-asserted-by":"publisher","unstructured":"Jollis JG, Granger CB, Z\u00e8gre-Hemsey JK, Henry TD, Goyal A, Tamis-Holland JE, et al. Treatment time and in-hospital mortality among patients with ST-segment elevation myocardial infarction, 2018\u20132021. JAMA. 2022;328(20):2033\u201340. https:\/\/doi.org\/10.1001\/jama.2022.20149.","DOI":"10.1001\/jama.2022.20149"},{"key":"6156_CR26","doi-asserted-by":"publisher","unstructured":"Wang B, Du Y, Cao P, Liu M, Yang J, Zhang N, et al. Development of a multidimensional prediction model for long-term prognostic risk in patients with acute coronary syndromes after percutaneous coronary intervention: a retrospective observational cohort study. PLoS One. 2025;20(5):e0318445. https:\/\/doi.org\/10.1371\/journal.pone.0318445.","DOI":"10.1371\/journal.pone.0318445"},{"key":"6156_CR27","doi-asserted-by":"publisher","unstructured":"Deng W, Wang D, Wan Y, Lai S, Ding Y, Wang X. Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review. Front Cardiovasc Med. 2024;10:1287434. https:\/\/doi.org\/10.3389\/fcvm.2023.1287434.","DOI":"10.3389\/fcvm.2023.1287434"},{"key":"6156_CR28","doi-asserted-by":"publisher","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. https:\/\/doi.org\/10.1186\/s12933-022-01511-x.","DOI":"10.1186\/s12933-022-01511-x"},{"key":"6156_CR29","doi-asserted-by":"publisher","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, et al. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2023;23(1):175. https:\/\/doi.org\/10.1186\/s12933-024-02263-6.","DOI":"10.1186\/s12933-024-02263-6"},{"key":"6156_CR30","doi-asserted-by":"publisher","unstructured":"Sergi D, Spaggiari R, Dalla Nora E, Angelini S, Castaldo F, Omenetto A, et al. HOMA-IR and TyG index differ for their relationship with dietary, anthropometric, inflammatory factors and capacity to predict cardiovascular risk. Diabetes Res Clin Pract. 2025;222:112103. https:\/\/doi.org\/10.1016\/j.diabres.2025.112103.","DOI":"10.1016\/j.diabres.2025.112103"},{"key":"6156_CR31","doi-asserted-by":"publisher","unstructured":"Huang Z, Ding X, Yue Q, Wang X, Chen Z, Cai Z, et al. Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):141. https:\/\/doi.org\/10.1186\/s12933-022-01577-7.","DOI":"10.1186\/s12933-022-01577-7"},{"key":"6156_CR32","doi-asserted-by":"publisher","unstructured":"Chen S, Mei Q, Guo L, Yang X, Luo W, Qu X, et al. Association between triglyceride-glucose index and atrial fibrillation: a retrospective observational study. Front Endocrinol. 2022;13:1047927. https:\/\/doi.org\/10.3389\/fendo.2022.1047927.","DOI":"10.3389\/fendo.2022.1047927"},{"key":"6156_CR33","doi-asserted-by":"publisher","unstructured":"Xia X, Chen S, Tian X, Xu Q, Zhang Y, Zhang X, et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc Diabetol. 2024;23(1):208. https:\/\/doi.org\/10.1186\/s12933-024-02290-3.","DOI":"10.1186\/s12933-024-02290-3"},{"key":"6156_CR34","doi-asserted-by":"publisher","unstructured":"Li X, Chan JSK, Guan B, Peng S, Wu X, Lu X, et al. Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis. Cardiovasc Diabetol. 2022;21(1):229. https:\/\/doi.org\/10.1186\/s12933-022-01658-7.","DOI":"10.1186\/s12933-022-01658-7"},{"key":"6156_CR35","doi-asserted-by":"publisher","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","DOI":"10.1186\/s12933-021-01268-9"},{"key":"6156_CR36","doi-asserted-by":"publisher","unstructured":"Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108. https:\/\/doi.org\/10.1186\/s12933-020-01086-5.","DOI":"10.1186\/s12933-020-01086-5"},{"key":"6156_CR37","doi-asserted-by":"publisher","unstructured":"Zeng D, Wang K, Chen Z, Yao C. Association between TyG index and long-term prognosis of patients with ST-segment elevated myocardial infarction undergoing percutaneous coronary intervention: a retrospective cohort study. BMJ Open. 2024;14(6). https:\/\/doi.org\/10.1136\/bmjopen-2023-079279.","DOI":"10.1136\/bmjopen-2023-079279"},{"key":"6156_CR38","doi-asserted-by":"publisher","unstructured":"Altekin RE, Kilinc AY, Onac M, Cicekcibasi O. Prognostic value of the residual SYNTAX score on in-hospital and follow-up clinical outcomes in ST elevation myocardial infarction patients undergoing percutaneous coronary interventions. Cardiol Res Pract. 2020;2020:9245431. https:\/\/doi.org\/10.1155\/2020\/9245431.","DOI":"10.1155\/2020\/9245431"},{"key":"6156_CR39","doi-asserted-by":"publisher","unstructured":"Reinstadler SJ, Kronbichler A, Reindl M, Tiller C, Holzknecht M, Oberhollenzer F, et al. Selective C-reactive protein apheresis in ST-elevation myocardial infarction: design and rationale of the randomized CRP-STEMI trial. Am Heart J. 2026;291:1\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2025.07.067.","DOI":"10.1016\/j.ahj.2025.07.067"},{"key":"6156_CR40","doi-asserted-by":"publisher","unstructured":"Mureddu GF, Faggiano A. Utility and limitations of ejection fraction and of diastolic dysfunction in heart failure patients. Monaldi Arch Chest Dis. 2019;89(1):1058. https:\/\/doi.org\/10.4081\/monaldi.2019.1058.","DOI":"10.4081\/monaldi.2019.1058"},{"key":"6156_CR41","doi-asserted-by":"publisher","unstructured":"Eggers KM, Hamilton E, Jernberg T, Lindahl B. Predictors of depressed left-ventricular ejection fraction after acute myocardial infarction. Int J Cardiol. 2026;445:134040. https:\/\/doi.org\/10.1016\/j.ijcard.2025.134040.","DOI":"10.1016\/j.ijcard.2025.134040"},{"key":"6156_CR42","doi-asserted-by":"publisher","unstructured":"North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097\u2013108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246876.","DOI":"10.1161\/CIRCRESAHA.111.246876"},{"key":"6156_CR43","doi-asserted-by":"publisher","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068\u201372. https:\/\/doi.org\/10.1161\/01.CIR.0000039105.49749.6F.","DOI":"10.1161\/01.CIR.0000039105.49749.6F"},{"key":"6156_CR44","doi-asserted-by":"publisher","unstructured":"Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. https:\/\/doi.org\/10.1186\/s12933-020-01054-z.","DOI":"10.1186\/s12933-020-01054-z"},{"key":"6156_CR45","doi-asserted-by":"publisher","unstructured":"Bortnick AE, Shitole SG, Hashim H, Khullar P, Park M, Weinreich M, et al. Residual SYNTAX II score and long-term outcomes post-ST-elevation myocardial infarction in an urban US cohort: the Montefiore STEMI Registry. Coron Artery Dis. 2022;33(3):206\u201312. https:\/\/doi.org\/10.1097\/MCA.0000000000001074.","DOI":"10.1097\/MCA.0000000000001074"},{"key":"6156_CR46","doi-asserted-by":"publisher","unstructured":"Li L, Liu S, Zhang Z, Zhou L, Zhang Z, Xiong Y, et al. Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status. Cardiovasc Diabetol. 2023;22(1):223. https:\/\/doi.org\/10.1186\/s12933-023-01932-2.","DOI":"10.1186\/s12933-023-01932-2"},{"key":"6156_CR47","doi-asserted-by":"publisher","unstructured":"Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, et al. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Am Heart J. 2010;159(1):131\u201340. https:\/\/doi.org\/10.1016\/j.ahj.2009.11.001.","DOI":"10.1016\/j.ahj.2009.11.001"},{"key":"6156_CR48","doi-asserted-by":"publisher","unstructured":"Qin Z, Du Y, Zhou Q, Lu X, Luo L, Zhang Z, et al. NT-proBNP and major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction who received primary percutaneous coronary intervention: a prospective cohort study. Cardiol Res Pract. 2021;2021:9943668. https:\/\/doi.org\/10.1155\/2021\/9943668.","DOI":"10.1155\/2021\/9943668"},{"key":"6156_CR49","doi-asserted-by":"publisher","unstructured":"Rathore SS, Weinfurt KP, Foody JM, Krumholz HM. Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients. Am Heart J. 2005;150(3):402\u201310. https:\/\/doi.org\/10.1016\/j.ahj.2005.03.069.","DOI":"10.1016\/j.ahj.2005.03.069"},{"key":"6156_CR50","doi-asserted-by":"publisher","unstructured":"Farooq V, Serruys PW, Bourantas CV,Zhang Y, Muramatsu T, Feldman T, et al. Quantification of incomplete revascularization and its association with five-year mortality in the SYNTAX trial: validation of the residual SYNTAX score. Circulation. 2013;128(2):141\u201351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001803.","DOI":"10.1161\/CIRCULATIONAHA.113.001803"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06156-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06156-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06156-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:07:38Z","timestamp":1790039258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06156-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6156"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06156-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Tianjin Medical University General Hospital (approval no. IRB2023-YX-301-01\/2023). Given that this was a retrospective analysis of clinically acquired data, the institutional review board waived the requirement for written informed consent from patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"824"}}